GOP House Leaders Want Answers from Becerra on Implementation and Impact of Medicare Drug Price Negotiation

Screenshot of Reps. Kevin Brady, Cathy McMorris Rodgers, and Kevin McCarthy on C-SPAN
Ranking Republicans Kevin Brady (left) and Cathy McMorris Rodgers (center) of House Ways & Means and Energy & Commerce committees sent a letter to HHS foreshadowing intensified oversight if Republicans win back control of the House in November.

Top U.S. House Republicans sent U.S. Health and Human Services Secretary Xavier Becerra a letter on Monday asking 18 detailed questions about implementation and oversight of the Inflation Reduction Act’s (IRA) Medicare drug price negotiation provisions. Their interrogation foreshadows intensified

Read More »

With Just a Month to Go, HRSA Releases First FY 2022 Manufacturer 340B Audit Result

Unichem building mounted sign
Unichem Pharmaceuticals USA must repay 340B covered entities for overcharges found during an FY 2022 340B program compliance audit.

Generic drug manufacturer Unichem Pharmaceuticals USA must repay 340B covered entities for overcharges found during a 340B program compliance audit, the U.S. Health Resources and Services Administration (HRSA) said yesterday.

HRSA has been auditing five drug manufacturers per year for

Read More »

Advocates Urge Feds to Allow Distressed Rural Hospitals to Remain 340B Eligible

Save Our Hospital lawn sign
Financially distressed critical access hospitals should be allowed to keep their 340B drug discounts if they opt under a new federal law to downgrade into emergency hospitals to remain solvent, rural health advocates told CMS in comments on proposed rules to implement the law.

Congress and the White House should let financially distressed critical access hospitals keep their 340B drug discounts if they opt under a new law to downgrade into emergency hospitals to remain solvent, rural health advocates told federal health officials in

Read More »

Key Takeaways from New Medicare Law and 340B Implications

President Biden signs law while legislators watch at the White House
President Biden signed the Inflation Reduction Act into law on Aug. 16.

The landmark prescription drug pricing legislation that President Joe Biden signed this month is a mixed bag for 340B stakeholders, 340B Health Publisher and CEO Ted Slafsky says in his latest column for Omnicell.

Biden signed the Inflation Reduction Act on

Read More »

Exclusive: HRSA Hasn’t Posted a Limited Distribution Plan Notice to 340B Entities in Almost a Year. No One Outside of the Agency Knows Why.

chart depicts limited distribution plan notices by HRSA in years from 2015 to 2022
HRSA has published no drug manufacturer limited distribution plan notices to 340B covered entities since mid-September 2021.

Last September, the U.S. Health Resources and Services Administration (HRSA) published a drug manufacturers’ notice to 340B covered entities that it was limiting distribution of a medicine that alleviates a side effect of HIV/AIDS treatment.

It was the fifth limited

Read More »

Judge Orders HHS to Respond to Ruling Letting Health Center Challenge 340B Patient Definition

Genesis health care pharmacy workers wearing face masks
A federal appeals court gave South Carolina-based Genesis Health Care another chance to challenge the legality of the 340B drug pricing program's patient definition.

A federal district judge on Tuesday gave federal health officials a Sept. 22 deadline to respond to a higher court’s ruling last month that a South Carolina health center has the right to challenge the legality of the government’s 340B

Read More »

House GOP Lawmaker Reintroduces Bill to Collect and Report 340B Hospital Data

Rep. Bruce Westerman (R-AR) headshot
U.S. Rep. Bruce Westerman (R-Ark.) has reintroduced a bill that would create new reporting requirements for 340B disproportionate share (DSH), children’s, and free-standing cancer hospitals and their child sites.

U.S. Rep. Bruce Westerman (R-Ark.) has reintroduced a comprehensive health care bill he sponsored during the last session of Congress that would create new reporting requirements for 340B disproportionate share (DSH), children’s, and free-standing cancer hospitals and their child sites.

Read More »

Sixth Group of 340B Hospitals Sues HHS Over Medicare Drug Payment Cuts

Oschner Medical Center hospital complex
New Orleans-based Ochsner Medical Center and six other 340B hospitals have sued in federal court to force HHS to immediately remedy illegal Medicare Part B drug payment cuts in place since 2018.

Correction, Friday, Aug. 26, 2022, 3:00 p.m. EDT—The original version of this article mistakenly said the hospital plaintiffs’ complaint stated that HHS improperly based 2020 and 2021 Medicare Part B drug payment cuts for 340B hospitals on a survey of

Read More »

GSK Announces Third Round of Refunds This Year for 340B Overcharges

GlaxoSmithKline wordmark building-mounted sign
GSK for the third time this year has announced refunds for overcharging 340B covered entities, this time for purchases during Q3 2020.

Drug manufacturer GlaxoSmithKline for the third time this year has announced refunds for overcharging 340B covered entities, this time for purchases of 16 NDCs during Q3 2020.

The U.S. Health Resources and Services Administration (HRSA) posted GSK’s notice to entities yesterday

Read More »

In Show of Support, House GOP Conference Chair Stefanik Visits 340B Contract Pharmacy

Rep. Elise Stefanik (R-NY) with contract pharmacy employees
U.S. Rep. Elise Stefanik of New York (second from left), the third highest-ranking House Republican, visited a 340B contract pharmacy in Plattsburgh last week in a show of support for the drug discount program.

Elise Stefanik (R-N.Y.), U.S. congresswoman for the 21st district in upstate New York and third highest-ranking Republican in the House of Representatives, visited independently-owned Condo Pharmacy in Plattsburgh, N.Y., last week in a show of support for the 340B contract pharmacy

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report